» Articles » PMID: 34883720

Fabrication of Tizanidine Loaded Patches Using Flaxseed Oil and Coriander Oil As a Penetration Enhancer for Transdermal Delivery

Abstract

Transdermal drug delivery is important to maintain plasma drug concentrations for therapeutic efficacy. The current study reports the design, formulation, and evaluation of tizanidine transdermal patches formulated using chitosan and thiolated chitosan, ethyl cellulose (EC), polyvinylpyrrolidone (PVP), and Eudragit RL100 in different ratios. The tizanidine patches were formulated using flaxseed oil and coriander oil in the concentrations of 1% /, 2% /, 3% /, 4% /, 5% /, and 10% /. The patches were subjected to characterization of physicochemical property (thickness, weight uniformity, drug content, efficiency, percentage moisture uptake/loss), in vitro drug release and drug permeation, skin irritation, in vivo application, pharmacokinetics analysis, and stability studies. The results indicate that the interaction of thiolated chitosan with the negative charges of the skin opens the tight junctions of the skin, whereas flaxseed and coriander oils change the conformational domain of the skin. The novelty of this study is in the use of flaxseed and coriander oils as skin permeation enhancers for the formulation of tizanidine transdermal patches. The formulations follow non-Fickian drug release kinetics. The FTZNE23, FTZNE36 and FTZNE54, with 5% / flaxseed oil loaded formulations, exhibited higher flux through rabbit skin compared with FTZNE30, FTZNE35, FTZNE42, and FTZNE47, formulations loaded with 10% / coriander oil. The study concludes that flaxseed oil is a better choice for formulating tizanidine patches, offering optimal plasma concentration and therapeutic efficacy, and recommends the use of flaxseed and coriander oil based patches as a novel transdermal delivery system for tizanidine and related classes of drugs.

Citing Articles

Chitosan-PVA-PVP/nano-clay composite: a promising tool for controlled drug delivery.

Ali M, Mir S, Atanase L, Abid O, Kazi M RSC Adv. 2024; 14(22):15777-15790.

PMID: 38752154 PMC: 11094589. DOI: 10.1039/d4ra02959c.


Strategies for the Preparation of Chitosan Derivatives for Antimicrobial, Drug Delivery, and Agricultural Applications: A Review.

Shrestha R, Thenissery A, Khupse R, Rajashekara G Molecules. 2023; 28(22).

PMID: 38005381 PMC: 10674490. DOI: 10.3390/molecules28227659.


Theoretical design for covering Engeletin with functionalized nanostructure-lipid carriers as neuroprotective agents against Huntington's disease via the nasal-brain route.

Smriti , Singla M, Gupta S, Porwal O, Binjawhar D, Sayed A Front Pharmacol. 2023; 14:1218625.

PMID: 37492081 PMC: 10364480. DOI: 10.3389/fphar.2023.1218625.


Synthesis of Bio-Based Polyester from Microbial Lipidic Residue Intended for Biomedical Application.

Capeto A, Azevedo-Silva J, Sousa S, Pintado M, Guimaraes A, Oliveira A Int J Mol Sci. 2023; 24(5).

PMID: 36901850 PMC: 10003017. DOI: 10.3390/ijms24054419.


The Therapeutic Application of Extract Loaded Nanoemulsion Cream for Acid-Burn Wound Healing and Skin Regeneration.

Gul H, Naseer R, Abbas I, Khan E, Rehman H, Nawaz A Medicina (Kaunas). 2023; 59(1).

PMID: 36676658 PMC: 9863468. DOI: 10.3390/medicina59010034.


References
1.
Sudhakar K, Fuloria S, Subramaniyan V, Sathasivam K, Azad A, Swain S . Ultraflexible Liposome Nanocargo as a Dermal and Transdermal Drug Delivery System. Nanomaterials (Basel). 2021; 11(10). PMC: 8537378. DOI: 10.3390/nano11102557. View

2.
Yener G, Uner M, Gonullu U, Yildirim S, Kilic P, Aslan S . Design of meloxicam and lornoxicam transdermal patches: Preparation, physical characterization, ex vivo and in vivo studies. Chem Pharm Bull (Tokyo). 2010; 58(11):1466-73. DOI: 10.1248/cpb.58.1466. View

3.
Marwah H, Garg T, Goyal A, Rath G . Permeation enhancer strategies in transdermal drug delivery. Drug Deliv. 2014; 23(2):564-78. DOI: 10.3109/10717544.2014.935532. View

4.
Rajan R, Vasudevan D . Effect of permeation enhancers on the penetration mechanism of transfersomal gel of ketoconazole. J Adv Pharm Technol Res. 2012; 3(2):112-6. PMC: 3401672. DOI: 10.4103/2231-4040.97286. View

5.
Mutalik S, Udupa N . Glibenclamide transdermal patches: physicochemical, pharmacodynamic, and pharmacokinetic evaluations. J Pharm Sci. 2004; 93(6):1577-94. DOI: 10.1002/jps.20058. View